In the battle to fight against male prostate problems scientist at Cancer Research UK have been able to identify a way to distinguish between benign and aggressive forms of prostrate cancer.
Their work involves perfecting a simple urine test that would enhance treatment, which in turn would lead to unnecessary surgery, or radiation treatment.
Doctor Lesley Walker of Cancer Research said: “Distinguishing the aggressive tumours that must be treated from those that do not need treatment will go along way towards resolving this issue.”
According to research published in the British Journal of Cancer it would appear that small bubbles of fat that appear in urine carry chemicals that would help doctors decide which cancers could spread.
What is the Prostate? Well, it is a gland found in the pelvis, its about the size of a satsuma orange and surrounds the urethra (the tube urine is passed from the bladder to the penis) and is only found in men.
My personal criticism is what plumber in his right mind would put a water pipe in-between to walls when he knows that both walls have a chance to move squashing the pipe and cutting of the supply of water.
That is exactly what the plumber did to the urethra tube. The urethra passes between the walls of the prostate gland which in later life is known to grow larger and, yes you’ve guessed it, when the prostate grows it presses the urethra between its two halves restricting urine flow from the bladder to the toilet via the urethra.
When this happens treatment is required to stop the pressure of the prostate on the urine tube. (I’ll bet the plumber never got the sack either. lol)
It should be remembered that if you start to have problems it is not wrote in stone that you have cancer, you should also not ignore any symptoms either as your symptoms are more likely to be caused by something else, such as benign prostatic hyperplasia (also known as BPH or prostate enlargement).
Update Prostate Cancer
Researchers at the John Hopkins University in Baltimore (USA) have discovered that by offering up large amounts of the hormone testosterone, which as always been thought of as the fuel to feed cancer, delivers such a shock it causes a shrinking of the tumours. The team have also successfully eliminated the cancer in one man who had stopped responding to treatment.
Professor Sam Denmeade, leading the research, from Johns Hopkins University School of Medicine in Baltimore, US, was quoted as saying “Our goal is to shock the cancer cells by exposing them rapidly to very high followed by very low levels of testosterone in the blood. The results are unexpected and exciting”.
Here in the United Kingdom (UK) some 47,000 men are diagnosed with prostate cancer each year. It is the most common cancer among UK men, and any research that can halt or kill this form of cancer can only be a good thing.